CDKN2A and pituitary gland adenoma: CDK inhibitors CDKN1B (p27), CDKN2A (p16), and CDKN2C (p18) are involved in G1-S transition, provide growth inhibitory signals and exhibit alterations in pituitary adenomas [32], [33].